According to the Zhitong Finance App, Yiming Onko-B (01541.HK) announced interim results for the six months ended June 30, 2026, with revenue of 25.424 million yuan (RMB, same below); R&D expenditure was 155 million yuan, a decrease of 7.9% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.